{"timestamp": 1771604696.3740895, "value": {"ticker": "AVIR", "company_name": "Atea Pharmaceuticals, Inc.", "short_name": "Atea Pharmaceuticals, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 367508480, "float_shares": 57964614, "shares_outstanding": 78126796, "short_ratio": 15.83, "short_percent_of_float": 0.1263, "shares_short": 7664024, "shares_short_prior": 6924486, "insider_percent_held": 0.13495, "institution_percent_held": 0.78161, "total_cash": 329308992, "total_debt": 1045000, "total_revenue": 0, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": 0.0, "debt_to_equity": 0.331, "current_ratio": 16.661, "book_value": 4.042, "price_to_book": 1.1637803, "operating_cashflow": -134205000, "free_cashflow": -76438752, "price": 4.704, "52w_high": 4.79, "52w_low": 2.455, "avg_volume": 445876, "avg_volume_10d": 529610, "full_time_employees": 56, "audit_risk": 6, "overall_risk": 8}}